Cargando…

Should we move to a genomic classification of neutrophilic myeloid neoplasms?

Detalles Bibliográficos
Autores principales: Carreño-Tarragona, Gonzalo, Álvarez-Larrán, Alberto, Hernández-Boluda, Juan Carlos, Ayala, Rosa, Cross, Nicholas C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641471/
https://www.ncbi.nlm.nih.gov/pubmed/37672387
http://dx.doi.org/10.1182/bloodadvances.2023011103
_version_ 1785146775047241728
author Carreño-Tarragona, Gonzalo
Álvarez-Larrán, Alberto
Hernández-Boluda, Juan Carlos
Ayala, Rosa
Cross, Nicholas C. P.
author_facet Carreño-Tarragona, Gonzalo
Álvarez-Larrán, Alberto
Hernández-Boluda, Juan Carlos
Ayala, Rosa
Cross, Nicholas C. P.
author_sort Carreño-Tarragona, Gonzalo
collection PubMed
description
format Online
Article
Text
id pubmed-10641471
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-106414712023-11-14 Should we move to a genomic classification of neutrophilic myeloid neoplasms? Carreño-Tarragona, Gonzalo Álvarez-Larrán, Alberto Hernández-Boluda, Juan Carlos Ayala, Rosa Cross, Nicholas C. P. Blood Adv Response The American Society of Hematology 2023-09-09 /pmc/articles/PMC10641471/ /pubmed/37672387 http://dx.doi.org/10.1182/bloodadvances.2023011103 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Response
Carreño-Tarragona, Gonzalo
Álvarez-Larrán, Alberto
Hernández-Boluda, Juan Carlos
Ayala, Rosa
Cross, Nicholas C. P.
Should we move to a genomic classification of neutrophilic myeloid neoplasms?
title Should we move to a genomic classification of neutrophilic myeloid neoplasms?
title_full Should we move to a genomic classification of neutrophilic myeloid neoplasms?
title_fullStr Should we move to a genomic classification of neutrophilic myeloid neoplasms?
title_full_unstemmed Should we move to a genomic classification of neutrophilic myeloid neoplasms?
title_short Should we move to a genomic classification of neutrophilic myeloid neoplasms?
title_sort should we move to a genomic classification of neutrophilic myeloid neoplasms?
topic Response
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641471/
https://www.ncbi.nlm.nih.gov/pubmed/37672387
http://dx.doi.org/10.1182/bloodadvances.2023011103
work_keys_str_mv AT carrenotarragonagonzalo shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms
AT alvarezlarranalberto shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms
AT hernandezboludajuancarlos shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms
AT ayalarosa shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms
AT crossnicholascp shouldwemovetoagenomicclassificationofneutrophilicmyeloidneoplasms